Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Orthofix Medical (OFIX) Shares Outstanding (2016 - 2026)

Orthofix Medical has reported Shares Outstanding over the past 18 years, most recently at $40.4 million for Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding rose 3.29% year-over-year to $40.4 million, compared with a TTM value of $40.4 million through Mar 2026, up 3.29%, and an annual FY2025 reading of $39.8 million, up 3.5% over the prior year.
  • Shares Outstanding came in at $40.4 million for Q1 2026, up from $39.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $40.4 million in Q1 2026 to a low of $19.8 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $37.4 million (2024), compared with a mean of $34.0 million.
  • The largest YoY upside for Shares Outstanding was 913.53% in 2022 against a maximum downside of 1.64% in 2022.
  • Over 5 years, Shares Outstanding stood at $20.2 million in 2022, then skyrocketed by 84.33% to $37.2 million in 2023, then increased by 3.55% to $38.5 million in 2024, then rose by 3.5% to $39.8 million in 2025, then rose by 1.38% to $40.4 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Shares Outstanding are $40.4 million (Q1 2026), $39.8 million (Q4 2025), and $39.5 million (Q3 2025).